| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometrial Neoplasms | 64 | 2023 | 1351 | 8.680 |
Why?
|
| Telomere | 67 | 2023 | 910 | 8.150 |
Why?
|
| Leukocytes | 45 | 2022 | 2045 | 4.200 |
Why?
|
| Genetic Predisposition to Disease | 79 | 2023 | 17446 | 1.910 |
Why?
|
| Polymorphism, Genetic | 34 | 2015 | 4328 | 1.820 |
Why?
|
| Polymorphism, Single Nucleotide | 75 | 2023 | 15520 | 1.600 |
Why?
|
| Genome-Wide Association Study | 46 | 2023 | 12262 | 1.400 |
Why?
|
| Case-Control Studies | 105 | 2023 | 21748 | 1.350 |
Why?
|
| Telomerase | 10 | 2023 | 730 | 1.320 |
Why?
|
| DNA, Mitochondrial | 11 | 2023 | 817 | 1.210 |
Why?
|
| Receptors, Progesterone | 6 | 2017 | 1098 | 1.060 |
Why?
|
| Nurses | 19 | 2017 | 2462 | 0.970 |
Why?
|
| Aging | 21 | 2023 | 8664 | 0.900 |
Why?
|
| Urinary Bladder Neoplasms | 16 | 2023 | 2249 | 0.900 |
Why?
|
| DNA Copy Number Variations | 11 | 2023 | 1941 | 0.870 |
Why?
|
| Genotype | 53 | 2024 | 12952 | 0.850 |
Why?
|
| Adenocarcinoma | 10 | 2016 | 6364 | 0.820 |
Why?
|
| Body Mass Index | 26 | 2023 | 12721 | 0.800 |
Why?
|
| Risk Factors | 109 | 2023 | 72296 | 0.760 |
Why?
|
| Middle Aged | 166 | 2023 | 213390 | 0.750 |
Why?
|
| Glutathione Transferase | 5 | 2011 | 595 | 0.740 |
Why?
|
| Ovarian Neoplasms | 16 | 2023 | 4839 | 0.740 |
Why?
|
| Glucuronosyltransferase | 5 | 2012 | 128 | 0.710 |
Why?
|
| Female | 221 | 2024 | 380193 | 0.710 |
Why?
|
| Alleles | 30 | 2021 | 6933 | 0.700 |
Why?
|
| Carbon | 2 | 2013 | 687 | 0.670 |
Why?
|
| Estradiol | 9 | 2012 | 2020 | 0.650 |
Why?
|
| DNA Methylation | 14 | 2023 | 4285 | 0.650 |
Why?
|
| Genetic Loci | 10 | 2017 | 2575 | 0.620 |
Why?
|
| Arylamine N-Acetyltransferase | 4 | 2023 | 86 | 0.600 |
Why?
|
| Coffee | 3 | 2020 | 578 | 0.600 |
Why?
|
| Humans | 278 | 2024 | 744366 | 0.600 |
Why?
|
| Genetic Variation | 18 | 2021 | 6542 | 0.590 |
Why?
|
| Postmenopause | 8 | 2012 | 2460 | 0.580 |
Why?
|
| Vitamin D | 4 | 2015 | 3224 | 0.580 |
Why?
|
| Adult | 133 | 2023 | 214052 | 0.570 |
Why?
|
| Diet | 14 | 2023 | 7937 | 0.570 |
Why?
|
| Smoking | 24 | 2017 | 8987 | 0.560 |
Why?
|
| Aromatase | 6 | 2009 | 147 | 0.530 |
Why?
|
| Diet, Mediterranean | 3 | 2020 | 700 | 0.530 |
Why?
|
| Paternal Age | 2 | 2012 | 84 | 0.530 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 381 | 0.510 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 5 | 2008 | 257 | 0.510 |
Why?
|
| Prospective Studies | 66 | 2023 | 53290 | 0.500 |
Why?
|
| Haplotypes | 12 | 2014 | 2779 | 0.470 |
Why?
|
| Skin Neoplasms | 13 | 2020 | 5692 | 0.460 |
Why?
|
| Aged | 92 | 2024 | 163288 | 0.450 |
Why?
|
| Phobic Disorders | 3 | 2018 | 439 | 0.450 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2017 | 783 | 0.450 |
Why?
|
| Talc | 2 | 2010 | 47 | 0.430 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2012 | 548 | 0.430 |
Why?
|
| Carcinoma, Basal Cell | 6 | 2016 | 545 | 0.430 |
Why?
|
| Breast Neoplasms | 22 | 2015 | 20824 | 0.420 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2004 | 245 | 0.420 |
Why?
|
| Caffeine | 5 | 2020 | 699 | 0.410 |
Why?
|
| Endometriosis | 4 | 2023 | 839 | 0.400 |
Why?
|
| Estradiol Dehydrogenases | 1 | 2010 | 15 | 0.390 |
Why?
|
| Social Class | 4 | 2023 | 1997 | 0.390 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2010 | 55 | 0.380 |
Why?
|
| Hydro-Lyases | 1 | 2010 | 94 | 0.380 |
Why?
|
| Arthritis, Rheumatoid | 6 | 2016 | 3712 | 0.380 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2011 | 123 | 0.370 |
Why?
|
| Vitamin B Complex | 1 | 2013 | 288 | 0.370 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2010 | 30 | 0.370 |
Why?
|
| Estrone | 6 | 2010 | 240 | 0.370 |
Why?
|
| Cohort Studies | 45 | 2023 | 40559 | 0.360 |
Why?
|
| Risk | 18 | 2020 | 9688 | 0.360 |
Why?
|
| Polymerase Chain Reaction | 15 | 2016 | 6171 | 0.360 |
Why?
|
| Obesity | 14 | 2023 | 12746 | 0.350 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2011 | 272 | 0.340 |
Why?
|
| Cross-Sectional Studies | 21 | 2023 | 25039 | 0.340 |
Why?
|
| Life Style | 8 | 2021 | 3835 | 0.340 |
Why?
|
| Reproduction | 3 | 2015 | 668 | 0.340 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2011 | 424 | 0.330 |
Why?
|
| Perineum | 1 | 2010 | 211 | 0.330 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2010 | 1203 | 0.330 |
Why?
|
| Antioxidants | 5 | 2021 | 1659 | 0.330 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 2190 | 0.320 |
Why?
|
| Hyperinsulinism | 2 | 2023 | 415 | 0.320 |
Why?
|
| Neoplasms | 12 | 2023 | 21696 | 0.320 |
Why?
|
| Leiomyoma | 3 | 2010 | 730 | 0.320 |
Why?
|
| Carotenoids | 4 | 2007 | 624 | 0.310 |
Why?
|
| Gene Frequency | 12 | 2018 | 3587 | 0.310 |
Why?
|
| Logistic Models | 22 | 2023 | 13409 | 0.310 |
Why?
|
| Melanoma | 7 | 2020 | 5511 | 0.300 |
Why?
|
| Uterine Neoplasms | 4 | 2013 | 1513 | 0.300 |
Why?
|
| Maternal Exposure | 3 | 2019 | 961 | 0.300 |
Why?
|
| Pancreatic Neoplasms | 7 | 2021 | 5263 | 0.300 |
Why?
|
| Exercise | 3 | 2020 | 5615 | 0.290 |
Why?
|
| Male | 98 | 2024 | 350115 | 0.290 |
Why?
|
| Gene Dosage | 4 | 2016 | 1252 | 0.290 |
Why?
|
| DNA | 8 | 2022 | 7294 | 0.290 |
Why?
|
| Nevus | 2 | 2020 | 204 | 0.280 |
Why?
|
| Nutritional Status | 3 | 2018 | 1609 | 0.280 |
Why?
|
| GATA5 Transcription Factor | 1 | 2006 | 18 | 0.280 |
Why?
|
| Isoenzymes | 3 | 2006 | 1728 | 0.280 |
Why?
|
| Receptors, Androgen | 4 | 2009 | 1058 | 0.280 |
Why?
|
| Diet Records | 4 | 2016 | 425 | 0.280 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2006 | 85 | 0.280 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 1364 | 0.270 |
Why?
|
| Oxidative Stress | 10 | 2023 | 3084 | 0.270 |
Why?
|
| Mitochondria | 5 | 2023 | 3514 | 0.270 |
Why?
|
| Research Design | 3 | 2022 | 5984 | 0.260 |
Why?
|
| Genes, p53 | 3 | 2007 | 755 | 0.260 |
Why?
|
| Models, Genetic | 6 | 2020 | 3493 | 0.260 |
Why?
|
| Odds Ratio | 17 | 2016 | 9849 | 0.250 |
Why?
|
| Stress Disorders, Post-Traumatic | 7 | 2018 | 4266 | 0.250 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2005 | 188 | 0.240 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2004 | 29 | 0.240 |
Why?
|
| Androgens | 2 | 2009 | 1281 | 0.240 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2004 | 769 | 0.240 |
Why?
|
| Longevity | 3 | 2021 | 1071 | 0.240 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2007 | 2916 | 0.240 |
Why?
|
| Incidence | 14 | 2023 | 20952 | 0.240 |
Why?
|
| Insulin Resistance | 1 | 2018 | 3864 | 0.240 |
Why?
|
| Women's Health | 7 | 2017 | 2034 | 0.240 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2022 | 1381 | 0.230 |
Why?
|
| Amino Acid Substitution | 3 | 2004 | 1793 | 0.230 |
Why?
|
| Testosterone | 2 | 2012 | 2419 | 0.230 |
Why?
|
| Multifactorial Inheritance | 3 | 2020 | 1195 | 0.230 |
Why?
|
| Phenol | 1 | 2023 | 43 | 0.230 |
Why?
|
| Menopause | 8 | 2021 | 1626 | 0.230 |
Why?
|
| United States | 39 | 2023 | 69872 | 0.230 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2022 | 1344 | 0.220 |
Why?
|
| Genetic Association Studies | 6 | 2016 | 2703 | 0.220 |
Why?
|
| Menarche | 2 | 2017 | 516 | 0.220 |
Why?
|
| Epigenesis, Genetic | 6 | 2023 | 3646 | 0.220 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2004 | 284 | 0.220 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 2016 | 0.220 |
Why?
|
| Life Change Events | 2 | 2023 | 938 | 0.220 |
Why?
|
| Mosaicism | 2 | 2016 | 441 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 5 | 2018 | 4805 | 0.210 |
Why?
|
| Proportional Hazards Models | 9 | 2020 | 12356 | 0.210 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2003 | 98 | 0.210 |
Why?
|
| Germ-Line Mutation | 3 | 2017 | 1788 | 0.210 |
Why?
|
| Confidence Intervals | 7 | 2013 | 2971 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2019 | 1677 | 0.210 |
Why?
|
| Follow-Up Studies | 22 | 2023 | 39052 | 0.210 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2022 | 967 | 0.210 |
Why?
|
| Body Height | 2 | 2020 | 1578 | 0.200 |
Why?
|
| Phenols | 2 | 2023 | 497 | 0.200 |
Why?
|
| DNA Damage | 4 | 2021 | 2432 | 0.200 |
Why?
|
| PPAR gamma | 1 | 2004 | 493 | 0.200 |
Why?
|
| Least-Squares Analysis | 2 | 2012 | 379 | 0.200 |
Why?
|
| Environment | 2 | 2023 | 1123 | 0.200 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2021 | 1352 | 0.190 |
Why?
|
| Diet Surveys | 2 | 2016 | 1173 | 0.190 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2003 | 323 | 0.190 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2441 | 0.190 |
Why?
|
| Anxiety Disorders | 1 | 2012 | 2690 | 0.190 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2017 | 711 | 0.190 |
Why?
|
| Apolipoprotein E4 | 2 | 2024 | 668 | 0.190 |
Why?
|
| Risk Assessment | 14 | 2020 | 23336 | 0.190 |
Why?
|
| Insulin | 2 | 2020 | 6582 | 0.190 |
Why?
|
| Barrett Esophagus | 2 | 2019 | 494 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2011 | 245 | 0.190 |
Why?
|
| Age Factors | 14 | 2021 | 18373 | 0.190 |
Why?
|
| DNA Repair | 5 | 2021 | 2046 | 0.180 |
Why?
|
| Urogenital Neoplasms | 1 | 2021 | 137 | 0.180 |
Why?
|
| Depression | 6 | 2020 | 7759 | 0.180 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2002 | 419 | 0.180 |
Why?
|
| Triclosan | 1 | 2019 | 55 | 0.170 |
Why?
|
| Longitudinal Studies | 14 | 2023 | 13991 | 0.170 |
Why?
|
| Mutation, Missense | 3 | 2009 | 2566 | 0.170 |
Why?
|
| Membrane Proteins | 6 | 2023 | 7882 | 0.170 |
Why?
|
| Occupational Diseases | 4 | 2014 | 1469 | 0.170 |
Why?
|
| Cholecalciferol | 1 | 2024 | 535 | 0.170 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2000 | 431 | 0.170 |
Why?
|
| Ovary | 2 | 2021 | 981 | 0.160 |
Why?
|
| Occupational Exposure | 3 | 2021 | 1793 | 0.160 |
Why?
|
| Astronauts | 1 | 2019 | 79 | 0.160 |
Why?
|
| Linkage Disequilibrium | 9 | 2016 | 1997 | 0.160 |
Why?
|
| Flavonols | 1 | 2018 | 83 | 0.160 |
Why?
|
| Vinyl Chloride | 2 | 1996 | 15 | 0.160 |
Why?
|
| Cholesterol, HDL | 3 | 2022 | 1813 | 0.160 |
Why?
|
| Siblings | 2 | 2020 | 854 | 0.160 |
Why?
|
| Inflammation | 8 | 2023 | 10637 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 8432 | 0.150 |
Why?
|
| Receptors, Adiponectin | 1 | 2018 | 82 | 0.150 |
Why?
|
| Colorectal Neoplasms | 4 | 2022 | 6773 | 0.150 |
Why?
|
| Folic Acid | 4 | 2013 | 1300 | 0.150 |
Why?
|
| DNA-Binding Proteins | 8 | 2014 | 9647 | 0.150 |
Why?
|
| Particulate Matter | 4 | 2018 | 2529 | 0.150 |
Why?
|
| Mammals | 1 | 2023 | 1143 | 0.150 |
Why?
|
| Cacao | 1 | 2018 | 98 | 0.150 |
Why?
|
| Cell Survival | 2 | 2023 | 5882 | 0.150 |
Why?
|
| Smoke | 1 | 2019 | 227 | 0.150 |
Why?
|
| Ribonucleoproteins | 2 | 2017 | 381 | 0.150 |
Why?
|
| Arachidonic Acid | 1 | 2018 | 434 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2010 | 351 | 0.150 |
Why?
|
| Estrogens | 4 | 2015 | 1566 | 0.150 |
Why?
|
| Life Expectancy | 1 | 2023 | 1184 | 0.140 |
Why?
|
| Health Surveys | 6 | 2020 | 4036 | 0.140 |
Why?
|
| Space Flight | 1 | 2019 | 188 | 0.140 |
Why?
|
| Dietary Supplements | 2 | 2018 | 3296 | 0.140 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2016 | 68 | 0.140 |
Why?
|
| Endocrine Disruptors | 1 | 2019 | 237 | 0.140 |
Why?
|
| Apoptosis | 4 | 2009 | 9724 | 0.140 |
Why?
|
| Residence Characteristics | 3 | 2023 | 2050 | 0.140 |
Why?
|
| Temperament | 1 | 2018 | 283 | 0.140 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.140 |
Why?
|
| Prognosis | 13 | 2020 | 29060 | 0.140 |
Why?
|
| Receptors, Leptin | 1 | 2018 | 361 | 0.140 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2015 | 17 | 0.140 |
Why?
|
| Alcohol Drinking | 4 | 2020 | 3966 | 0.140 |
Why?
|
| DNA, Neoplasm | 5 | 2012 | 1758 | 0.140 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2000 | 604 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2021 | 11726 | 0.130 |
Why?
|
| Disease-Free Survival | 4 | 2021 | 6896 | 0.130 |
Why?
|
| Epigenomics | 2 | 2023 | 903 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 133 | 0.130 |
Why?
|
| Anesthetics, Inhalation | 1 | 2021 | 570 | 0.130 |
Why?
|
| Fertilization in Vitro | 1 | 2003 | 1284 | 0.130 |
Why?
|
| Population Groups | 1 | 2016 | 209 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 1097 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2016 | 197 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2014 | 403 | 0.130 |
Why?
|
| ROC Curve | 1 | 2023 | 3528 | 0.130 |
Why?
|
| Phthalic Acids | 1 | 2019 | 436 | 0.130 |
Why?
|
| Homocysteine | 1 | 2018 | 647 | 0.130 |
Why?
|
| Depressive Disorder, Major | 4 | 2018 | 4639 | 0.130 |
Why?
|
| Aged, 80 and over | 16 | 2022 | 57776 | 0.130 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 9445 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2016 | 380 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 2 | 2017 | 577 | 0.120 |
Why?
|
| Phenotype | 9 | 2020 | 16367 | 0.120 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 296 | 0.120 |
Why?
|
| Caregivers | 2 | 2018 | 2095 | 0.120 |
Why?
|
| Carcinogens | 2 | 2012 | 466 | 0.120 |
Why?
|
| Pilot Projects | 5 | 2023 | 8319 | 0.120 |
Why?
|
| Estrogen Receptor beta | 1 | 2015 | 175 | 0.120 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2014 | 45 | 0.120 |
Why?
|
| Cholesterol, LDL | 2 | 2022 | 2355 | 0.120 |
Why?
|
| Menstrual Cycle | 2 | 2015 | 551 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2011 | 1157 | 0.120 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 224 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2020 | 1915 | 0.120 |
Why?
|
| Genome, Human | 3 | 2015 | 4420 | 0.120 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2014 | 32 | 0.120 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 808 | 0.120 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2018 | 582 | 0.120 |
Why?
|
| Cyclin E | 1 | 2014 | 172 | 0.120 |
Why?
|
| Apolipoproteins E | 3 | 2024 | 1438 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2016 | 4034 | 0.120 |
Why?
|
| MicroRNAs | 2 | 2022 | 3751 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 15078 | 0.120 |
Why?
|
| Puberty | 1 | 2017 | 490 | 0.120 |
Why?
|
| Body Fat Distribution | 1 | 2015 | 244 | 0.120 |
Why?
|
| Saliva | 2 | 2015 | 809 | 0.120 |
Why?
|
| Transplantation Conditioning | 1 | 2020 | 1599 | 0.120 |
Why?
|
| Receptor, Insulin | 1 | 2018 | 847 | 0.120 |
Why?
|
| Triglycerides | 2 | 2020 | 2453 | 0.120 |
Why?
|
| Casein Kinase II | 1 | 2014 | 128 | 0.120 |
Why?
|
| Dementia | 1 | 2008 | 2518 | 0.120 |
Why?
|
| Work Schedule Tolerance | 2 | 2023 | 563 | 0.120 |
Why?
|
| Gallstones | 1 | 2016 | 286 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 94 | 0.110 |
Why?
|
| Europe | 6 | 2021 | 3338 | 0.110 |
Why?
|
| Genes, ras | 3 | 2008 | 690 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2014 | 367 | 0.110 |
Why?
|
| Welding | 1 | 2014 | 89 | 0.110 |
Why?
|
| Mutagens | 1 | 2014 | 168 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1837 | 0.110 |
Why?
|
| Health Behavior | 2 | 2016 | 2635 | 0.110 |
Why?
|
| Polycyclic Compounds | 1 | 1992 | 32 | 0.110 |
Why?
|
| Epidemiologic Studies | 4 | 2018 | 676 | 0.110 |
Why?
|
| Antigens, CD | 2 | 2018 | 4026 | 0.110 |
Why?
|
| Intrauterine Devices | 1 | 2014 | 122 | 0.110 |
Why?
|
| Love | 1 | 2013 | 37 | 0.110 |
Why?
|
| Mixed Tumor, Mullerian | 1 | 2013 | 56 | 0.110 |
Why?
|
| Intestinal Polyps | 1 | 1993 | 100 | 0.110 |
Why?
|
| Anemia, Aplastic | 1 | 2015 | 226 | 0.110 |
Why?
|
| Carcinogens, Environmental | 1 | 1992 | 67 | 0.110 |
Why?
|
| Cause of Death | 3 | 2020 | 3582 | 0.110 |
Why?
|
| Hemangiosarcoma | 2 | 1996 | 239 | 0.110 |
Why?
|
| Genetic Markers | 4 | 2023 | 2634 | 0.110 |
Why?
|
| Child Abuse, Sexual | 1 | 2015 | 383 | 0.110 |
Why?
|
| Critical Pathways | 1 | 2016 | 476 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 1312 | 0.100 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2013 | 129 | 0.100 |
Why?
|
| Disabled Children | 1 | 2014 | 247 | 0.100 |
Why?
|
| Genomic Instability | 2 | 2019 | 695 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2020 | 1620 | 0.100 |
Why?
|
| Genomic Imprinting | 3 | 2017 | 328 | 0.100 |
Why?
|
| Adiponectin | 1 | 2018 | 1101 | 0.100 |
Why?
|
| Vitamin B 6 | 1 | 2013 | 237 | 0.100 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2011 | 20 | 0.100 |
Why?
|
| Cooking | 1 | 2014 | 313 | 0.100 |
Why?
|
| Cell Division | 2 | 1998 | 4569 | 0.100 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2011 | 52 | 0.100 |
Why?
|
| Occupations | 1 | 2014 | 517 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2014 | 4554 | 0.100 |
Why?
|
| Sex Factors | 4 | 2020 | 10400 | 0.100 |
Why?
|
| Infant, Premature | 1 | 2021 | 2045 | 0.100 |
Why?
|
| Choline | 1 | 2013 | 493 | 0.100 |
Why?
|
| Prostatic Neoplasms | 4 | 2023 | 11126 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2023 | 10483 | 0.100 |
Why?
|
| Premenopause | 3 | 2008 | 1033 | 0.100 |
Why?
|
| Chromosome Aberrations | 2 | 2015 | 1813 | 0.100 |
Why?
|
| Inhalation Exposure | 1 | 2014 | 443 | 0.100 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2010 | 31 | 0.090 |
Why?
|
| Leukocyte Count | 1 | 2014 | 1588 | 0.090 |
Why?
|
| Receptors, Calcitriol | 1 | 2013 | 348 | 0.090 |
Why?
|
| Neoplasm Proteins | 2 | 2014 | 3707 | 0.090 |
Why?
|
| Psychosocial Deprivation | 1 | 2011 | 99 | 0.090 |
Why?
|
| Environmental Pollutants | 1 | 2019 | 1179 | 0.090 |
Why?
|
| Methionine | 1 | 2013 | 590 | 0.090 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2013 | 271 | 0.090 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2011 | 129 | 0.090 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2010 | 96 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 4 | 2015 | 3616 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 749 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 705 | 0.090 |
Why?
|
| Meditation | 1 | 2013 | 242 | 0.090 |
Why?
|
| Child, Institutionalized | 1 | 2011 | 108 | 0.090 |
Why?
|
| Vitamin B 12 | 1 | 2013 | 527 | 0.090 |
Why?
|
| Gene Expression | 2 | 2021 | 7798 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2015 | 1063 | 0.090 |
Why?
|
| Quantitative Trait Loci | 4 | 2020 | 2019 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2000 | 2850 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2010 | 326 | 0.090 |
Why?
|
| Cognition Disorders | 3 | 2011 | 4043 | 0.090 |
Why?
|
| Anesthesia | 1 | 2021 | 1561 | 0.090 |
Why?
|
| Resilience, Psychological | 1 | 2016 | 677 | 0.090 |
Why?
|
| Probability | 2 | 2021 | 2506 | 0.090 |
Why?
|
| Maternal Age | 1 | 2012 | 802 | 0.090 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2016 | 706 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 2016 | 931 | 0.080 |
Why?
|
| Reference Values | 3 | 2007 | 4982 | 0.080 |
Why?
|
| Lung Neoplasms | 8 | 2020 | 13104 | 0.080 |
Why?
|
| Nails | 2 | 2014 | 292 | 0.080 |
Why?
|
| Linear Models | 3 | 2017 | 5953 | 0.080 |
Why?
|
| Breast Feeding | 1 | 2017 | 1338 | 0.080 |
Why?
|
| BRCA1 Protein | 1 | 2015 | 1149 | 0.080 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2008 | 5 | 0.080 |
Why?
|
| Adolescent | 15 | 2021 | 85779 | 0.080 |
Why?
|
| Parturition | 1 | 2012 | 441 | 0.080 |
Why?
|
| Codon | 2 | 2004 | 611 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 365 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1613 | 0.080 |
Why?
|
| Rhodopsin | 1 | 2009 | 203 | 0.080 |
Why?
|
| Anthropometry | 2 | 2016 | 1350 | 0.080 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 19905 | 0.080 |
Why?
|
| Child Development | 1 | 2020 | 2223 | 0.080 |
Why?
|
| Adiposity | 1 | 2018 | 1806 | 0.080 |
Why?
|
| Depressive Disorder | 2 | 2018 | 3747 | 0.080 |
Why?
|
| Perception | 1 | 2014 | 1198 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 1998 | 5023 | 0.080 |
Why?
|
| HLA-DR Antigens | 1 | 2010 | 645 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2008 | 65 | 0.080 |
Why?
|
| Colonic Polyps | 1 | 1993 | 542 | 0.080 |
Why?
|
| Hormones | 2 | 2003 | 889 | 0.080 |
Why?
|
| Metabolomics | 1 | 2016 | 1485 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3047 | 0.080 |
Why?
|
| Parents | 3 | 2020 | 3405 | 0.080 |
Why?
|
| Hydrolases | 1 | 2008 | 139 | 0.080 |
Why?
|
| Calcium | 2 | 2013 | 5755 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2009 | 535 | 0.080 |
Why?
|
| Socioeconomic Factors | 5 | 2023 | 7785 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2134 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2008 | 399 | 0.070 |
Why?
|
| Disease Susceptibility | 2 | 2004 | 1782 | 0.070 |
Why?
|
| Young Adult | 13 | 2023 | 56429 | 0.070 |
Why?
|
| Neoplasm Staging | 5 | 2013 | 11031 | 0.070 |
Why?
|
| Base Sequence | 4 | 2009 | 12797 | 0.070 |
Why?
|
| Prolactin | 1 | 2009 | 669 | 0.070 |
Why?
|
| Carcinoma in Situ | 1 | 2013 | 806 | 0.070 |
Why?
|
| Venous Thromboembolism | 2 | 2017 | 1671 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2008 | 297 | 0.070 |
Why?
|
| Environmental Exposure | 2 | 2019 | 4232 | 0.070 |
Why?
|
| Alanine | 2 | 2009 | 572 | 0.070 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1994 | 1692 | 0.070 |
Why?
|
| CpG Islands | 2 | 2022 | 1170 | 0.070 |
Why?
|
| Ethanol | 1 | 2013 | 1342 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 4 | 2006 | 5867 | 0.070 |
Why?
|
| NFATC Transcription Factors | 1 | 2008 | 381 | 0.070 |
Why?
|
| Stress, Psychological | 3 | 2018 | 4245 | 0.070 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 1031 | 0.070 |
Why?
|
| Retinitis Pigmentosa | 1 | 2009 | 386 | 0.070 |
Why?
|
| Self Report | 2 | 2018 | 3553 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2014 | 3390 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2008 | 730 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2015 | 2241 | 0.060 |
Why?
|
| Regression Analysis | 3 | 2014 | 6459 | 0.060 |
Why?
|
| Neuroendocrine Tumors | 1 | 2011 | 594 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 1998 | 4666 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 3 | 2014 | 1342 | 0.060 |
Why?
|
| Androstenedione | 1 | 2004 | 131 | 0.060 |
Why?
|
| Air Pollution | 1 | 2018 | 2286 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2010 | 1355 | 0.060 |
Why?
|
| Body Size | 1 | 2007 | 461 | 0.060 |
Why?
|
| Flavonoids | 1 | 2007 | 443 | 0.060 |
Why?
|
| Estrogens, Catechol | 1 | 2004 | 25 | 0.060 |
Why?
|
| Air Pollutants | 1 | 2018 | 2816 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 1832 | 0.060 |
Why?
|
| Glucuronides | 1 | 2004 | 20 | 0.060 |
Why?
|
| Survival Rate | 4 | 2021 | 12788 | 0.060 |
Why?
|
| Trinucleotide Repeats | 1 | 2005 | 261 | 0.060 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2008 | 484 | 0.060 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2006 | 300 | 0.060 |
Why?
|
| Ketone Bodies | 1 | 2023 | 82 | 0.060 |
Why?
|
| Rectal Neoplasms | 1 | 1993 | 1205 | 0.060 |
Why?
|
| Lung | 3 | 2022 | 9857 | 0.060 |
Why?
|
| Anxiety | 1 | 2018 | 4293 | 0.060 |
Why?
|
| Proteins | 3 | 2014 | 6100 | 0.060 |
Why?
|
| Genomics | 2 | 2016 | 5717 | 0.060 |
Why?
|
| Animals | 11 | 2023 | 168768 | 0.060 |
Why?
|
| RNA | 1 | 2013 | 2749 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2019 | 9955 | 0.060 |
Why?
|
| Infant | 7 | 2021 | 35134 | 0.060 |
Why?
|
| Pregnancy | 7 | 2020 | 29144 | 0.060 |
Why?
|
| Acetaminophen | 1 | 2007 | 545 | 0.060 |
Why?
|
| Mutation | 6 | 2017 | 29786 | 0.060 |
Why?
|
| Leucine | 1 | 2004 | 560 | 0.050 |
Why?
|
| Hypertriglyceridemia | 1 | 2006 | 293 | 0.050 |
Why?
|
| Australia | 3 | 2012 | 1167 | 0.050 |
Why?
|
| Valine | 1 | 2004 | 413 | 0.050 |
Why?
|
| Organ Size | 1 | 2008 | 2251 | 0.050 |
Why?
|
| Selenium | 1 | 2005 | 405 | 0.050 |
Why?
|
| Infant, Newborn | 5 | 2021 | 25628 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2011 | 2943 | 0.050 |
Why?
|
| Poland | 2 | 2012 | 184 | 0.050 |
Why?
|
| Health Resources | 1 | 2009 | 911 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2002 | 127 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2008 | 16690 | 0.050 |
Why?
|
| beta Carotene | 1 | 2003 | 527 | 0.050 |
Why?
|
| Adenoma | 1 | 1993 | 2174 | 0.050 |
Why?
|
| Sleep | 2 | 2023 | 4622 | 0.050 |
Why?
|
| Cardiovascular Diseases | 4 | 2017 | 15160 | 0.050 |
Why?
|
| Massachusetts | 5 | 2015 | 8662 | 0.050 |
Why?
|
| Liver Neoplasms | 2 | 1996 | 4253 | 0.050 |
Why?
|
| Fertility | 2 | 2021 | 781 | 0.050 |
Why?
|
| Embryo Implantation | 1 | 2003 | 272 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8038 | 0.050 |
Why?
|
| Motor Activity | 1 | 2012 | 2715 | 0.050 |
Why?
|
| Age Distribution | 1 | 2007 | 2902 | 0.050 |
Why?
|
| Personality Inventory | 1 | 2004 | 1030 | 0.050 |
Why?
|
| Ultraviolet Rays | 2 | 2016 | 1060 | 0.050 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2022 | 227 | 0.050 |
Why?
|
| Sarcoma | 1 | 2013 | 1897 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2887 | 0.050 |
Why?
|
| Hospitalization | 1 | 2021 | 10259 | 0.050 |
Why?
|
| Endometrium | 1 | 2004 | 424 | 0.050 |
Why?
|
| Fetal Blood | 2 | 2018 | 1318 | 0.050 |
Why?
|
| Child | 10 | 2021 | 77709 | 0.050 |
Why?
|
| Epithelial Cells | 2 | 2010 | 3690 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 12244 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 1081 | 0.050 |
Why?
|
| Endophenotypes | 1 | 2022 | 250 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2021 | 117 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4751 | 0.050 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2021 | 115 | 0.050 |
Why?
|
| Survival Analysis | 3 | 2020 | 10252 | 0.050 |
Why?
|
| Vitamin D Deficiency | 1 | 2010 | 1343 | 0.050 |
Why?
|
| China | 3 | 2012 | 2245 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2003 | 434 | 0.050 |
Why?
|
| Child, Preschool | 6 | 2021 | 41005 | 0.050 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2000 | 335 | 0.050 |
Why?
|
| Nitrous Oxide | 1 | 2021 | 176 | 0.050 |
Why?
|
| Signal Transduction | 4 | 2018 | 23404 | 0.050 |
Why?
|
| Menopause, Premature | 1 | 2021 | 132 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 3922 | 0.040 |
Why?
|
| Molecular Sequence Data | 5 | 2009 | 18111 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2004 | 1802 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2010 | 2616 | 0.040 |
Why?
|
| Epidemiologic Research Design | 1 | 2003 | 367 | 0.040 |
Why?
|
| United States National Aeronautics and Space Administration | 1 | 2019 | 15 | 0.040 |
Why?
|
| Chi-Square Distribution | 3 | 2014 | 3508 | 0.040 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 1660 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2022 | 3921 | 0.040 |
Why?
|
| Vitamins | 2 | 2005 | 1623 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2019 | 6598 | 0.040 |
Why?
|
| Melphalan | 1 | 2020 | 431 | 0.040 |
Why?
|
| Nitrosamines | 1 | 2019 | 87 | 0.040 |
Why?
|
| Flavanones | 1 | 2019 | 71 | 0.040 |
Why?
|
| Binding Sites | 2 | 2006 | 6111 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2013 | 3265 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 871 | 0.040 |
Why?
|
| Glioma | 1 | 2013 | 3401 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 631 | 0.040 |
Why?
|
| Catechin | 1 | 2018 | 66 | 0.040 |
Why?
|
| Oxidants | 1 | 2019 | 164 | 0.040 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2017 | 14 | 0.040 |
Why?
|
| South Africa | 1 | 2023 | 1731 | 0.040 |
Why?
|
| Women | 1 | 2020 | 230 | 0.040 |
Why?
|
| Air Pollutants, Occupational | 1 | 2021 | 408 | 0.040 |
Why?
|
| Fruit | 2 | 2019 | 1142 | 0.040 |
Why?
|
| Spain | 2 | 2010 | 465 | 0.040 |
Why?
|
| Vegetables | 2 | 2019 | 1182 | 0.040 |
Why?
|
| Chromosome Mapping | 3 | 2012 | 4740 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2000 | 802 | 0.040 |
Why?
|
| Placenta | 2 | 2017 | 1699 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 1085 | 0.040 |
Why?
|
| Ketones | 1 | 2019 | 188 | 0.040 |
Why?
|
| Isoflurane | 1 | 2021 | 380 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2020 | 302 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 2542 | 0.040 |
Why?
|
| Fasting | 1 | 2023 | 1592 | 0.040 |
Why?
|
| Dopamine | 1 | 2004 | 1591 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10943 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 711 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2282 | 0.040 |
Why?
|
| New Hampshire | 2 | 2008 | 172 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2005 | 2307 | 0.040 |
Why?
|
| Cotinine | 1 | 2017 | 206 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5445 | 0.040 |
Why?
|
| Urinary Bladder | 2 | 2014 | 1173 | 0.040 |
Why?
|
| Sex Characteristics | 3 | 2012 | 2585 | 0.040 |
Why?
|
| Registries | 3 | 2023 | 8091 | 0.040 |
Why?
|
| SEER Program | 1 | 2021 | 1507 | 0.040 |
Why?
|
| Personality Assessment | 1 | 2018 | 647 | 0.040 |
Why?
|
| Heterozygote | 3 | 2009 | 2804 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2017 | 1862 | 0.030 |
Why?
|
| Genetic Drift | 1 | 2016 | 43 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A1 | 2 | 2008 | 91 | 0.030 |
Why?
|
| Death Certificates | 1 | 2016 | 169 | 0.030 |
Why?
|
| Molecular Epidemiology | 2 | 1996 | 468 | 0.030 |
Why?
|
| Psychology | 1 | 2018 | 356 | 0.030 |
Why?
|
| Cognition | 2 | 2024 | 6770 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1998 | 473 | 0.030 |
Why?
|
| Interleukin-1beta | 2 | 2014 | 972 | 0.030 |
Why?
|
| Retroviridae | 1 | 1998 | 914 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2002 | 2373 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2003 | 2016 | 0.030 |
Why?
|
| Hippocampus | 1 | 2008 | 3675 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 1998 | 913 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2009 | 12025 | 0.030 |
Why?
|
| Causality | 1 | 2022 | 1275 | 0.030 |
Why?
|
| Aspirin | 1 | 2007 | 3283 | 0.030 |
Why?
|
| Health Occupations | 1 | 2016 | 224 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2022 | 1809 | 0.030 |
Why?
|
| Feeding Behavior | 2 | 2019 | 3188 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2019 | 950 | 0.030 |
Why?
|
| Karyotyping | 1 | 2016 | 1243 | 0.030 |
Why?
|
| Receptors, GABA-B | 1 | 2014 | 68 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2024 | 6994 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2021 | 781 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2012 | 1730 | 0.030 |
Why?
|
| Homozygote | 2 | 2009 | 1787 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2000 | 1142 | 0.030 |
Why?
|
| Chile | 1 | 2014 | 237 | 0.030 |
Why?
|
| Labor Unions | 1 | 2014 | 47 | 0.030 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 58 | 0.030 |
Why?
|
| Exons | 1 | 2000 | 2439 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2016 | 365 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 714 | 0.030 |
Why?
|
| Prevalence | 3 | 2017 | 15221 | 0.030 |
Why?
|
| Nicotine | 1 | 2019 | 681 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2004 | 2147 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2015 | 517 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2008 | 2775 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 553 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 14723 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2019 | 1382 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 232 | 0.030 |
Why?
|
| Alu Elements | 1 | 2014 | 119 | 0.030 |
Why?
|
| Air | 1 | 2014 | 182 | 0.030 |
Why?
|
| Data Collection | 1 | 2023 | 3339 | 0.030 |
Why?
|
| Protein Binding | 3 | 2006 | 9384 | 0.030 |
Why?
|
| Weight Gain | 1 | 2023 | 2293 | 0.030 |
Why?
|
| Sister Chromatid Exchange | 1 | 1992 | 60 | 0.030 |
Why?
|
| Pigmentation | 1 | 2013 | 148 | 0.030 |
Why?
|
| Carcinoma | 1 | 2004 | 2375 | 0.030 |
Why?
|
| tau Proteins | 1 | 2022 | 1868 | 0.030 |
Why?
|
| Glutathione S-Transferase pi | 2 | 2003 | 97 | 0.030 |
Why?
|
| Genetic Pleiotropy | 1 | 2014 | 182 | 0.030 |
Why?
|
| Michigan | 1 | 2013 | 350 | 0.030 |
Why?
|
| Phylogeny | 1 | 2000 | 2804 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 1994 | 2949 | 0.030 |
Why?
|
| Metals, Heavy | 1 | 2014 | 139 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 2917 | 0.030 |
Why?
|
| Algorithms | 2 | 2020 | 13882 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2014 | 316 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6313 | 0.030 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1994 | 362 | 0.030 |
Why?
|
| Cholesterol | 2 | 2016 | 2919 | 0.030 |
Why?
|
| Weight Loss | 1 | 2023 | 2625 | 0.030 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2014 | 338 | 0.030 |
Why?
|
| Marital Status | 1 | 2013 | 437 | 0.030 |
Why?
|
| Time Factors | 4 | 2019 | 40075 | 0.030 |
Why?
|
| Sunlight | 1 | 2013 | 325 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2005 | 6194 | 0.020 |
Why?
|
| Telomeric Repeat Binding Protein 1 | 1 | 2010 | 5 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2015 | 917 | 0.020 |
Why?
|
| Overweight | 1 | 2022 | 2371 | 0.020 |
Why?
|
| Hair Color | 1 | 2011 | 136 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2008 | 5223 | 0.020 |
Why?
|
| Contraception | 1 | 2014 | 359 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2014 | 690 | 0.020 |
Why?
|
| Religion | 1 | 2014 | 356 | 0.020 |
Why?
|
| Mice | 5 | 2021 | 81201 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 2013 | 564 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2021 | 2576 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 1125 | 0.020 |
Why?
|
| Stroke | 1 | 2013 | 9981 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 2795 | 0.020 |
Why?
|
| Foster Home Care | 1 | 2011 | 129 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 703 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2017 | 1783 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 4642 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2015 | 881 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 3587 | 0.020 |
Why?
|
| Selection Bias | 1 | 2011 | 371 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2015 | 9145 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 6386 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3486 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 806 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2009 | 58 | 0.020 |
Why?
|
| Parity | 1 | 2012 | 929 | 0.020 |
Why?
|
| Finland | 1 | 2010 | 602 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2008 | 68 | 0.020 |
Why?
|
| Gestational Age | 1 | 2017 | 3493 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 733 | 0.020 |
Why?
|
| Transcription Factors | 3 | 2003 | 12207 | 0.020 |
Why?
|
| Camptothecin | 1 | 2012 | 576 | 0.020 |
Why?
|
| Comorbidity | 1 | 2023 | 10388 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2014 | 1200 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 2012 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2010 | 340 | 0.020 |
Why?
|
| Microdissection | 1 | 2008 | 152 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1994 | 988 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3130 | 0.020 |
Why?
|
| Body Weight | 1 | 2019 | 4671 | 0.020 |
Why?
|
| Sample Size | 1 | 2011 | 845 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2008 | 216 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2021 | 3318 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2010 | 980 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2010 | 798 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2009 | 188 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 1641 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 1590 | 0.020 |
Why?
|
| India | 1 | 2014 | 2197 | 0.020 |
Why?
|
| Pain | 1 | 2023 | 4988 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11366 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2009 | 288 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1889 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2009 | 204 | 0.020 |
Why?
|
| Electroretinography | 1 | 2009 | 509 | 0.020 |
Why?
|
| Liver | 2 | 2012 | 7475 | 0.020 |
Why?
|
| Lipids | 1 | 2018 | 3307 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 1994 | 975 | 0.020 |
Why?
|
| Hospitals | 1 | 2021 | 3954 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1707 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2014 | 1904 | 0.020 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2010 | 546 | 0.020 |
Why?
|
| Seasons | 1 | 1992 | 1493 | 0.020 |
Why?
|
| Chromatin | 1 | 2018 | 2933 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2010 | 77460 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 4777 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 1992 | 1414 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2009 | 880 | 0.020 |
Why?
|
| Pancreatic Ducts | 1 | 2008 | 328 | 0.020 |
Why?
|
| Glycine | 1 | 2009 | 671 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 130 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1378 | 0.020 |
Why?
|
| Public Health Nursing | 1 | 2005 | 15 | 0.020 |
Why?
|
| Educational Status | 1 | 2013 | 2540 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6366 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2015 | 5101 | 0.020 |
Why?
|
| Veterans | 1 | 2018 | 2519 | 0.020 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1596 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 2086 | 0.020 |
Why?
|
| Fats, Unsaturated | 1 | 2003 | 21 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6539 | 0.010 |
Why?
|
| Lasers | 1 | 2008 | 952 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2575 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2014 | 3203 | 0.010 |
Why?
|
| DNA Ligases | 1 | 2003 | 80 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 1152 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 21833 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2003 | 53 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2530 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2009 | 1461 | 0.010 |
Why?
|
| Epitopes | 1 | 2010 | 2571 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2008 | 2716 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2716 | 0.010 |
Why?
|
| Violence | 1 | 2009 | 909 | 0.010 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 2002 | 32 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3511 | 0.010 |
Why?
|
| Verbal Learning | 1 | 2005 | 468 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2861 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1998 | 19233 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1994 | 3873 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 4424 | 0.010 |
Why?
|
| International Cooperation | 1 | 2009 | 1420 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3778 | 0.010 |
Why?
|
| Computational Biology | 1 | 2014 | 3519 | 0.010 |
Why?
|
| Proline | 1 | 2003 | 458 | 0.010 |
Why?
|
| TATA Box | 1 | 2001 | 128 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15535 | 0.010 |
Why?
|
| Body Composition | 1 | 2010 | 2402 | 0.010 |
Why?
|
| Methyltransferases | 1 | 2003 | 367 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13286 | 0.010 |
Why?
|
| Family | 1 | 2010 | 3147 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2006 | 7721 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 20130 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 6036 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 4262 | 0.010 |
Why?
|
| Healthcare Disparities | 1 | 2014 | 3154 | 0.010 |
Why?
|
| Memory, Short-Term | 1 | 2005 | 977 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 1998 | 66 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2013 | 7730 | 0.010 |
Why?
|
| Histone Chaperones | 1 | 1998 | 76 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 992 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 63107 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 13035 | 0.010 |
Why?
|
| Internet | 1 | 2009 | 3056 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1998 | 1101 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 4257 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 1783 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 5749 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1998 | 1202 | 0.010 |
Why?
|
| France | 1 | 1996 | 517 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1992 | 12073 | 0.010 |
Why?
|
| Silicosis | 1 | 1994 | 45 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2006 | 3280 | 0.010 |
Why?
|
| Asbestosis | 1 | 1994 | 82 | 0.010 |
Why?
|
| Receptor, erbB-2 | 2 | 1994 | 2417 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 1995 | 334 | 0.010 |
Why?
|
| Health Personnel | 1 | 2007 | 3219 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 2839 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1998 | 13814 | 0.010 |
Why?
|
| Mass Screening | 1 | 2009 | 5253 | 0.010 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 1998 | 735 | 0.010 |
Why?
|
| Growth Substances | 1 | 1995 | 784 | 0.010 |
Why?
|
| Asbestos | 1 | 1994 | 251 | 0.010 |
Why?
|
| Mammography | 1 | 2003 | 2475 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 1994 | 420 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 1998 | 3848 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1994 | 1683 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 970 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1992 | 1247 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1994 | 1100 | 0.000 |
Why?
|
| Lymphatic Metastasis | 1 | 1994 | 2924 | 0.000 |
Why?
|
| Myocardium | 1 | 1998 | 4772 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1992 | 4010 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1996 | 2214 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1998 | 11486 | 0.000 |
Why?
|
| Peptides | 1 | 1992 | 4410 | 0.000 |
Why?
|